Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Hiroko Yamagami"'
Publikováno v:
研究紀要. 33:1-7
要旨 本研究の目的は,40 代と50 代の中年期の男女を対象にして,理想自己と現実自己の差異と困難な目標への対処との関連を量的と質的の両方のアプローチから検討することであった。
Autor:
Hiroko, YAMAGAMI
Publikováno v:
児童学研究 : 聖徳大学児童学研究所紀要. 25:41-49
要旨 思春期に入ったばかりの中学生は,自分の将来への夢は未だ不確かであり,「志向する生き方」についても非現実的で,漠然としたイメージを描いていることが考えられる。本研究
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Nozomi Kinoshita, Ayumi Ota, Fumihiko Toyoda, Hiroko Yamagami, Akihiro KakehashiDepartment of Ophthalmology, Saitama Medical Center, Jichi Medical University, Saitama, JapanPurpose: To report on pars plana vitrectomy (PPV) combined with pars plana le
Autor:
Hiroyuki Tamemoto, Hiroto Ueba, Chiho Kambara, Akihiro Kakehashi, Ayumi Ota, Masanobu Kawakami, Yoh Dobashi, Hiroko Yamagami, Fumihiko Toyoda, San-e Ishikawa, Yasunori Kanazawa, Nozomi Kinoshita
Publikováno v:
The Open Diabetes Journal. 4:108-113
Advanced glycation end products (AGEs) play important roles in the development of ocular complications in diabetes mellitus. Spontaneously Diabetic Torii (SDT) rats have marked hyperglycemia and severe ocular complications. We evaluated the effect of
Autor:
Mikiko Takezawa, Noriaki Kato, Hiroko Yamagami, Masanobu Kawakami, Fumihiko Toyoda, Chiho Kambara, Yasunori Kanazawa, Akihiro Kakehashi, Nozomi Kinoshita, San-e Ishikawa
Publikováno v:
The Open Diabetes Journal. 4:101-107
We evaluated the effect of an aldose reductase inhibitor, fidarestat, on diabetic retinopathy (DR) and cataract in spontaneously diabetic Torii (SDT) rats. Four rat groups were included: untreated, low- and high-dose (8 and 32 mg/kg/day) fidarestat-t
Autor:
Nozomi Kinoshita, Akihiro Kakehashi, Hiroko Yamagami, Kana Hashimoto, Masanobu Kawakami, San-e Ishikawa, Fumihiko Toyoda, Chiho Kanbara, Hiroyuki Tamemoto, Yasunori Kanazawa, Yoh Dobashi
Publikováno v:
The Open Diabetes Journal. 4:41-44
Background/Aims: The Spontaneously Diabetic Torii (SDT) rat develops advanced diabetic retinopathy (DR). The aim of this study was to identify advanced glycation end products (AGEs) related to vascular endothelial growth factor (VEGF) expression, a c
Autor:
Ken Sato, Miki Sato, Satoko Aoki, Takakazu Higuchi, Shun Ichi Kimura, Kentaro Yoshinaga, Junji Nishida, Shinichi Kako, Fumiya Miyamura, Kumi Oshima, Kiriko Terasako, Shinya Okuda, Hiroko Yamagami, Akihiro Kakehashi, Rie Yamazaki, Toshio Demitsu, Hideki Nakasone, Yoshinobu Kanda
Publikováno v:
International Journal of Hematology. 90:397-401
Only some carriers of human T cell lymphotropic virus type I (HTLV-1) develop adult T cell leukemia/lymphoma (ATLL) after a long latency period, and an association has been reported between chronic refractory eczema, known as infective dermatitis, an
Autor:
Mitsuaki Isobe, Junko Hori, Satoru Yamagami, Hitoshi Endo, Hiroko Yamagami, Tadahiko Tsuru, Hidetoshi Kawashima, Yasuo Kagawa, Hirohumi Shibui
Publikováno v:
Transplantation. 66:1504-1510
Background.Cytokine profile is a key in understanding the mechanisms of allograft rejection. Cytokine expression in the aqueous humor and the correlation between the aqueous humor cells and corneal infiltrating cells are not fully understood in corne
Autor:
Hideo Yagita, Ko Okumura, Dale S. Gregerson, Nobuhiko Kayagaki, Hiroko Yamagami, Tadahiko Tsuru, Hidetoshi Kawashima, Satoru Yamagami
Publikováno v:
Transplantation. 64:1107-1111
Background. The expression of Fas ligand (FasL) in the eye has been proposed to be an important component of ocular immune privilege. Since the unusually favorable outcome of corneal transplantation is thought to result from the immune privilege of t
Publikováno v:
Transplantation. 64:42-48
BACKGROUND: The mechanisms of corneal xenogeneic immunoreaction, as well as the potential role of immunosuppressive therapy in the suppression of corneal xenograft rejection, have not been thoroughly explored. METHODS: BALB/c mice who received orthot